Skip to main content
OpenTrials

Clinical trial condition

Atypical Hemolytic Uremic Syndrome

Explore clinical trials studying Atypical Hemolytic Uremic Syndrome. Study availability and eligibility vary by location and protocol.

33 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Atypical Hemolytic Uremic Syndrome trial results

Completed

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ of California at Los Angeles Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Univ of California at Sacramento Sacramento, California, United States
View all 36 locations
View Trial Details
Completed

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

NCT02222545

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Omeros Investigational Site Duarte, California, United States
  • Omeros Investigational Site Rochester, Minnesota, United States
  • Omeros Investigational Site New York, United States
  • Omeros Investigational Site Durham, North Carolina, United States
View all 24 locations
View Trial Details
Completed

Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT03131219

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Research Site Hollywood, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Detroit, Michigan, United States
  • Research Site Omaha, Nebraska, United States
View all 18 locations
View Trial Details
Completed

Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT02949128

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Clinical Trial Site Fort Wayne, Indiana, United States
  • Clinical Trial Site Fort Wayne, Indiana, United States
  • Clinical Trial Site Durham, North Carolina, United States
  • Clinical Trial Site Winston-Salem, North Carolina, United States
View all 37 locations
View Trial Details
Completed

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

NCT03518203

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +19 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT01770951

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Dunwoody, Georgia, United States
  • Chicago, Illinois, United States
  • Portland, Maine, United States
  • Boston, Massachusetts, United States
View all 23 locations
View Trial Details

Related conditions